The ERBB receptor inhibitor dacomitinib suppresses proliferation and invasion of pancreatic ductal adenocarcinoma cells.

Momeny, Majid

The ERBB receptor inhibitor dacomitinib suppresses proliferation and invasion of pancreatic ductal adenocarcinoma cells. [electronic resource] - Cellular oncology (Dordrecht, Netherlands) Aug 2019 - 491-504 p. digital

Publication Type: Journal Article

2211-3436

10.1007/s13402-019-00448-w doi


Apoptosis--drug effects
Carcinoma, Pancreatic Ductal--drug therapy
Cell Line, Tumor
Cell Movement--drug effects
Cell Proliferation--drug effects
Cell Survival--drug effects
ErbB Receptors--antagonists & inhibitors
Humans
Models, Biological
Neoplasm Invasiveness
Pancreatic Neoplasms--drug therapy
Quinazolinones--pharmacology
Radiation Tolerance